Media-OutReach Newswire CK Life Sciences’ Investigational Cancer Vaccines Deliver Promising Results - New Preclinical Study Data to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting
Media-OutReach Newswire CK Life Sciences Files Patent Applications for Circular mRNA TROP2 Cancer Vaccine
Media-OutReach Newswire Li Ka Shing Foundation and Temasek Trust Jointly Commit S$12 Million to Acquire Systems and Advance Clinical Trial for Innovative Histotripsy Cancer Therapy in Singapore